Nowadays, GDM has almost turned into a worldwide epidemic and can be considered a short-term metabolic syndrome that is accompanied by hyperglycemia and oxidative stress-related inflammation, which may alter intracellular signaling pathways including insulin signaling pathways [39]. The gene discussed is INS; the disease is Hyperglycemia.